Coronavirus: Check here for latest ChristianaCare visitor and other information. >

Addiction Medicine

ChristianaCare Teams with Pear Therapeutics to Provide New Treatment for Substance Use Disorders

Patients in Delaware and surrounding communities seeking treatment for opioid and substance use disorders will now have access to an innovative treatment option called prescription digital therapeutics (PDTs), in a collaboration between ChristianaCare and Pear Therapeutics, Inc. The treatment is approved by the Food and Drug Administration (FDA). ChristianaCare is advancing its leadership in harnessing value-based digital […] Read more